Kindred Healthcare, Inc. (NYSE:KND) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday, August 30th.
According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “
Other equities analysts have also recently issued reports about the company. UBS AG restated a “neutral” rating and issued a $10.50 target price (up from $8.00) on shares of Kindred Healthcare in a report on Friday, May 5th. BidaskClub cut Kindred Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Mizuho restated a “neutral” rating and issued a $9.00 target price on shares of Kindred Healthcare in a report on Monday, July 3rd. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $10.00 target price on shares of Kindred Healthcare in a research report on Monday, May 15th. Finally, Deutsche Bank AG decreased their target price on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, August 7th. Five equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. Kindred Healthcare presently has a consensus rating of “Hold” and a consensus target price of $9.94.
Shares of Kindred Healthcare (KND) traded up 0.69% during midday trading on Wednesday, hitting $7.25. 2,594,932 shares of the stock were exchanged. The company’s market cap is $630.89 million. The firm has a 50 day moving average of $7.78 and a 200-day moving average of $9.28. Kindred Healthcare has a one year low of $5.65 and a one year high of $11.90.
Kindred Healthcare (NYSE:KND) last issued its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Kindred Healthcare had a positive return on equity of 3.49% and a negative net margin of 16.31%. The firm’s revenue for the quarter was down 4.6% on a year-over-year basis. During the same period last year, the firm earned $0.38 EPS. Equities analysts expect that Kindred Healthcare will post $0.47 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by BBNS and is owned by of BBNS. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://baseballnewssource.com/markets/kindred-healthcare-inc-knd-rating-lowered-to-sell-at-zacks-investment-research/1566273.html.
Several large investors have recently made changes to their positions in KND. BlackRock Inc. lifted its position in shares of Kindred Healthcare by 41,968.4% in the first quarter. BlackRock Inc. now owns 10,779,191 shares of the health services provider’s stock worth $90,006,000 after buying an additional 10,753,568 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Kindred Healthcare by 40.9% in the first quarter. Wellington Management Group LLP now owns 7,945,247 shares of the health services provider’s stock worth $66,342,000 after buying an additional 2,307,814 shares during the last quarter. Point72 Asset Management L.P. lifted its position in shares of Kindred Healthcare by 303.1% in the first quarter. Point72 Asset Management L.P. now owns 1,734,899 shares of the health services provider’s stock worth $14,486,000 after buying an additional 1,304,499 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Kindred Healthcare by 149.4% in the second quarter. JPMorgan Chase & Co. now owns 2,104,618 shares of the health services provider’s stock worth $24,518,000 after buying an additional 1,260,753 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in shares of Kindred Healthcare by 102.3% in the second quarter. Goldman Sachs Group Inc. now owns 1,753,787 shares of the health services provider’s stock worth $20,431,000 after buying an additional 886,906 shares during the last quarter. 88.72% of the stock is owned by institutional investors.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with our FREE daily email newsletter.